Literature DB >> 19421770

The effectiveness of FloSeal matrix hemostatic agent in thyroid surgery: a prospective, randomized, control study.

Mario Testini1, Rinaldo Marzaioli, Germana Lissidini, Agostino Lippolis, Francesco Logoluso, Angela Gurrado, Domenica Lardo, Elisabetta Poli, Giuseppe Piccinni.   

Abstract

BACKGROUND: The objective of this study was to compare the effectiveness of FloSeal matrix hemostatic agent with hemostatic surgical procedures and Tabotamp in thyroid surgery.
METHODS: One hundred fifty-five consecutive total thyroidectomy patients were recruited at our institution between January 2005 and December 2007. Exclusion criteria were applied. Patients were randomized to one of three hemostatic approaches: 49 received surgical procedures only, and 52 received oxidized regenerated cellulose patch (Tabotamp Fibrillar 2.5 x 5 cm) and 54 FloSeal (5,000 U/5 mL). The same surgeon performed all operations.
RESULTS: Mean operating time was reduced in the FloSeal group (105 min) vs. surgical (133 min, p = 0.02) and vs. Tabotamp (122 min, p = 0.0003). Also, wound drain removal occurred earlier with FloSeal (p = 0.006 vs. surgical; p = 0.008 vs. Tabotamp) resulting in shorter postoperative hospital stay in the FloSeal group (p = 0.02 vs. surgical; p = 0.002 vs. Tabotamp).
CONCLUSIONS: FloSeal matrix is an effective additional agent to conventional haemostatic procedures in thyroid surgery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19421770     DOI: 10.1007/s00423-009-0497-5

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  28 in total

1.  [Improvement of hemostasis in laparoscopic and open partial nephrectomy with gelatin thrombin matrix (FloSeal)].

Authors:  F Richter; M E Tüllmann; I Türk; S Deger; J Roigas; A Wille; D Schnorr
Journal:  Urologe A       Date:  2003-02-05       Impact factor: 0.639

2.  The impact of single parathyroid gland autotransplantation during thyroid surgery on postoperative hypoparathyroidism: a multicenter study.

Authors:  M Testini; L Rosato; N Avenia; F Basile; P Portincasa; G Piccinni; G Lissidini; A Biondi; A Gurrado; M Nacchiero
Journal:  Transplant Proc       Date:  2007 Jan-Feb       Impact factor: 1.066

3.  Cervical haematoma after thyroid surgery: management and prevention.

Authors:  M Shandilya; S Kieran; P Walshe; C Timon
Journal:  Ir Med J       Date:  2006-10

4.  Reexploration for symptomatic hematomas after cervical exploration.

Authors:  S H Burkey; J A van Heerden; G B Thompson; C S Grant; C D Schleck; D R Farley
Journal:  Surgery       Date:  2001-12       Impact factor: 3.982

5.  Evaluation of FloSeal as a potential intracavitary hemostatic agent.

Authors:  Harold G Klemcke
Journal:  J Trauma       Date:  2006-02

6.  Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in patients with acute anterior epistaxis.

Authors:  Ronald A Mathiasen; Raul M Cruz
Journal:  Laryngoscope       Date:  2005-05       Impact factor: 3.325

7.  Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery.

Authors:  Fred A Weaver; Douglas B Hood; Michael Zatina; Louis Messina; Brian Badduke
Journal:  Ann Vasc Surg       Date:  2002-04-18       Impact factor: 1.466

8.  Use of a novel topical hemostatic sealant in lacrimal surgery: a prospective, comparative study.

Authors:  Omar M Durrani; Arosha I Fernando; Tristan Q Reuser
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2007 Jan-Feb       Impact factor: 1.746

Review 9.  Use of FloSeal hemostatic sealant in transsphenoidal pituitary surgery: technical note.

Authors:  Dilantha B Ellegala; Nicholas F Maartens; Edward R Laws
Journal:  Neurosurgery       Date:  2002-08       Impact factor: 4.654

10.  Airway complications in thyroid surgery.

Authors:  L Lacoste; D Gineste; J Karayan; N Montaz; M S Lehuede; M Girault; A F Bernit; J Barbier; J Fusciardi
Journal:  Ann Otol Rhinol Laryngol       Date:  1993-06       Impact factor: 1.547

View more
  17 in total

1.  Bleeding control in pedicle subtraction osteotomy.

Authors:  Claudio Lamartina; Giovanni Casero
Journal:  Eur Spine J       Date:  2011-12       Impact factor: 3.134

Review 2.  Prevention and management of bleeding in thyroid surgery.

Authors:  Gabriele Materazzi; Carlo Enrico Ambrosini; Lorenzo Fregoli; Luigi De Napoli; Gianluca Frustaci; Valeria Matteucci; Piermarco Papini; Sohail Bakkar; Paolo Miccoli
Journal:  Gland Surg       Date:  2017-10

3.  Improvement of Perioperative Outcomes in Major Gynecological and Gynecologic-Oncological Surgery with Hemostatic Gelatin-Thrombin Matrix.

Authors:  Rafał Watrowski; Christoph Jäger; Johannes Forster
Journal:  In Vivo       Date:  2017 Mar-Apr       Impact factor: 2.155

4.  The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition.

Authors:  Donat R Spahn; Bertil Bouillon; Vladimir Cerny; Jacques Duranteau; Daniela Filipescu; Beverley J Hunt; Radko Komadina; Marc Maegele; Giuseppe Nardi; Louis Riddez; Charles-Marc Samama; Jean-Louis Vincent; Rolf Rossaint
Journal:  Crit Care       Date:  2019-03-27       Impact factor: 9.097

5.  Haemostatics in surgery and our experience in the enucleoresection of renal cell carcinoma.

Authors:  Gianna Pace; Pietro Saldutto; Carlo Vicentini; Lucio Miano
Journal:  World J Surg Oncol       Date:  2010-05-12       Impact factor: 2.754

Review 6.  Management of bleeding and coagulopathy following major trauma: an updated European guideline.

Authors:  Donat R Spahn; Bertil Bouillon; Vladimir Cerny; Timothy J Coats; Jacques Duranteau; Enrique Fernández-Mondéjar; Daniela Filipescu; Beverley J Hunt; Radko Komadina; Giuseppe Nardi; Edmund Neugebauer; Yves Ozier; Louis Riddez; Arthur Schultz; Jean-Louis Vincent; Rolf Rossaint
Journal:  Crit Care       Date:  2013-04-19       Impact factor: 9.097

7.  The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition.

Authors:  Rolf Rossaint; Bertil Bouillon; Vladimir Cerny; Timothy J Coats; Jacques Duranteau; Enrique Fernández-Mondéjar; Daniela Filipescu; Beverley J Hunt; Radko Komadina; Giuseppe Nardi; Edmund A M Neugebauer; Yves Ozier; Louis Riddez; Arthur Schultz; Jean-Louis Vincent; Donat R Spahn
Journal:  Crit Care       Date:  2016-04-12       Impact factor: 9.097

8.  Hemostatic agent use in thyroid surgery: a meta-analysis.

Authors:  Helmi Khadra; Mohamed Bakeer; Adam Hauch; Tian Hu; Emad Kandil
Journal:  Gland Surg       Date:  2018-08

9.  Evaluation of local hemostatic effect of microporous polysaccharide hemospheres products in thyroid surgery: a prospective randomized controlled study.

Authors:  Enver Kunduz; Erhan Aysan; Ufuk Oğuz İdiz; Yeliz Emine Ersoy; Hüseyin Kazım Bektaşoğlu; Samet Yığman; Hacer Kundakcıoğlu
Journal:  Turk J Surg       Date:  2019-03-01

10.  The efficacy of a thrombin-based hemostatic agent in primary total knee arthroplasty: a meta-analysis.

Authors:  Chen Wang; Zhe Han; Tao Zhang; Jian-xiong Ma; Xuan Jiang; Ying Wang; Xin-long Ma
Journal:  J Orthop Surg Res       Date:  2014-10-15       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.